Published on Dec 20, 2022 and last reviewed on Sep 19, 2023 - 6 min read
Abstract
Inhibiting angiogenesis using angiogenesis inhibitors helps prevent cancer growth. Read this article to know more about it.
Angiogenesis is defined as the process of forming new blood vessels from pre-existing vasculature formed in the early stage of vasculogenesis (the process of blood vessel formation in the embryo). It occurs throughout life, beginning in utero and continuing till old age. It plays a vital role in growth, development, and wound healing. The two types of angiogenesis include;
Sprouting Angiogenesis: In sprouting angiogenesis, new blood vessels sprout or bud from the pre-existing vessels.
Intussusceptive Angiogenesis: It is also called splitting angiogenesis. In intussusceptive angiogenesis, new blood vessels are formed by splitting the pre-existing blood vessel into two.
Angiogenesis is stimulated by various growth factors called angiogenic growth factors. The different angiogenic growth factors that stimulate angiogenesis include
Basic fibroblast growth factor (bFGF).
Granulocyte colony-stimulating growth factor (G-CSF).
Vascular endothelial growth factor (VEGF).
Transforming growth factor-alpha and beta.
Platelet-derived growth factor (PDGF).
Interleukin-8 (IL-8).
Vascular endothelial growth factors secreted by tumor cells stimulate blood vessel growth and allow for tumor growth and expansion.
The tumor requires blood supply to grow beyond a few millimeters in size. In general, tumor cells lack blood supply, due to which the growth of the tumor is blocked up to a specific time. However, at times the tumor may start secreting angiogenic growth factors that stimulate the formation of new blood vessels from pre-existing blood vessels. As a result, the newly formed blood vessels feed the tumor with oxygen and nutrients allowing the tumor to enlarge and leading cancer cells to invade the nearby tissue. Therefore inhibiting angiogenesis is necessary for controlling tumor growth. A specific type of drug named angiogenesis inhibitors are used to inhibit angiogenesis.
Drugs that inhibit angiogenesis are referred to as angiogenesis inhibitors. It is also called an anti-angiogenic drug. The main goal of angiogenesis inhibitors in cancer treatment is to prevent new blood vessel formation that stimulates tumor growth rather than blocking the growth of tumor cells.
Angiogenesis inhibitors inhibit new blood vessel growth in different ways. Some angiogenesis inhibitors are monoclonal antibodies that specifically bind to vascular endothelial growth factor (VEGF) and target it. The vascular endothelial growth factor cannot activate its receptors when the angiogenesis inhibitors bind to it.
The other mechanism by which angiogenesis inhibitors work is blocking the angiogenesis growth factor signaling pathway that stimulates tumor growth. Some angiogenesis inhibitors act as immunomodulatory agents that prevent tumor growth by stimulating or suppressing the immune system.
Angiogenesis inhibitors prevent tumor growth by inhibiting angiogenesis rather than blocking cancer cell growth. Therefore combining angiogenesis inhibitors with other cancer treatments is found to be more effective in treating certain types of cancer.
Angiogenesis inhibitors can be given either alone or in combination with other cancer treatments. Several angiogenesis inhibitors are approved by the FDA (Food and Drug Administration) for treating different types of cancers. The angiogenesis inhibitors approved by FDA include;
1. Bevacizumab: Bevacizumab is used for treating cervical, colorectal, kidney, liver, and non-small cell lung cancers. It can also treat ovarian, peritoneal, and fallopian tube cancers.
2. Axitinib: It is used to treat kidney cancer.
3. Cabozantinib: It is used for the treatment of;
Liver cancer.
Differentiated thyroid cancer.
Medullary thyroid cancer.
4. Everolimus: Is used for the treatment of;
Breast cancer.
Kidney cancer.
Neuroendocrine lung cancer.
Gastrointestinal neuroendocrine tumors.
Pancreatic neuroendocrine tumors (PNET).
Subependymal giant cell astrocytoma (a type of noncancerous brain tumor).
5. Lenvatinib: Is proven to be beneficial in the treatment of;
Liver cancer.
Thyroid cancer.
Kidney cancer.
Endometrial carcinoma.
6. Lenalidomide: Is used for the treatment of;
Follicular lymphoma - Follicular lymphoma is a very slow-growing cancer that appears in the lymph nodes of the bone marrow and other organs.
Mantle cell lymphoma - Mantle cell lymphoma is a rare blood cancer that occurs in the white blood cells in the lymph nodes.
Marginal zone lymphoma -This is a type of Non-Hodgkin’s lymphoma that can transform into a more aggressive lymphoma (cancer).
Multiple myeloma - This is a condition in which plasma cells become cancerous.
7. Ramucirumab: It is approved to treat;
Liver cancer.
Non-small cell lung cancer.
Stomach adenocarcinoma.
8. Regorafenib: It is used for the treatment of;
Colorectal cancer.
Gastrointestinal stromal tumor.
9. Thalidomide: It is used for the treatment of multiple myeloma. It is not recommended for pregnant ladies because it may lead to severe birth defects.
10. Vandetanib: It is authorized for the treatment of medullary thyroid cancer.
11. Pazopanib Hydrochloride: It is employed in treating kidney cancer and soft tissue sarcoma.
12. Ziv-aflibercept: It is used for the treatment of colorectal cancer.
The doctor can prescribe angiogenesis inhibitors in the form of oral pills or be given intravenously (IV). Before taking angiogenesis inhibitors, the patients are advised to discuss the side effects associated with the drug. In addition, the patients should take the medicines at regular intervals as prescribed by the doctor to avoid missing a dose. If a dose is missed, then the patient should inform the doctor.
Angiogenesis plays a vital role in normal growth and development and wound healing. Therefore inhibiting angiogenesis can cause a wide range of side effects. The most common symptoms of angiogenesis inhibitors include;
Fatigue.
Diarrhea.
Delayed wound healing.
Skin rashes.
Dry and itchy skin.
Low blood cell counts.
High blood pressure.
Hand-foot syndrome (a syndrome that causes numbness, tingling, swelling, and burning sensations in hands and feet).
If angiogenesis inhibitors cause any side effects in patients, then they should inform the healthcare provider. The healthcare provider will help manage the symptoms by prescribing some medicines.
Our diet can play a significant role in cancer prevention and control. Some foods that we eat in our daily life can help us fight against cancer. One such food that helps prevent tumor growth is anti-angiogenic foods. Anti-angiogenic foods are mainly plant-based foods with some naturally occurring anti-angiogenic substances that help prevent angiogenesis. The most common examples of anti-angiogenic foods are;
Green tea.
Different types of berries, such as blackberries, raspberries, and gooseberries.
Red wine.
Dark chocolate.
Fruits like watermelon, citrus fruits, and avocados.
Green leafy vegetables.
Conclusion:
Tumor growth is stimulated by angiogenesis; inhibiting angiogenesis can help block tumor growth and recurrence. Angiogenesis inhibitors help inhibit angiogenesis in cancer. FDA has approved various angiogenesis inhibitors for cancer treatments. Angiogenesis inhibitors treat cancer only by blocking tumor growth rather than tumor cell growth; therefore, combining angiogenesis inhibitors with other cancer treatments is more effective.
Developing new blood vessels from the vasculature that already exists during the early stages of vasculogenesis is known as angiogenesis. It happens from conception until old age, all the way through life. It is essential for development, growth, and wound healing.
The tumor needs a blood supply to expand beyond a few millimeters in size. Tumor cells do not receive enough blood, preventing the tumor from growing until a certain point. The tumor may occasionally begin secreting angiogenic growth factors, which encourage the development of new blood vessels from pre-existing ones.
Angiogenesis is a typical and intricate process that the body's biomolecules regulate. Endothelial and smooth muscle cell actions are coordinated by endogenous local or systemic chemical cues to restore blood vessel injuries.
A key factor in the development of cancer is angiogenesis. New blood vessels form for the growth of tumors, and this process is known as angiogenesis. Chemicals released by the tumor and host cells near the tumor promote this process.
Solid tumors require a blood supply to grow larger than a few millimeters. Angiogenesis is crucial to the development of cancer. By emitting chemical signals that encourage angiogenesis, tumors can trigger the formation of this blood supply.
Cells in the affected area emit chemical signals that trigger angiogenesis when certain tissues are hypoxic (low oxygen levels). It resembles an SOS call for assistance. As a result, endothelial cells that line the blood arteries organize themselves to promote the growth of new capillaries.
No, tumors can trigger the formation of this blood supply by emitting chemical signals that encourage angiogenesis. Moreover, tumors can induce adjacent normal cells to create angiogenesis signaling molecules.
Yes, angiogenesis enables the transport of oxygen, nutrients, growth factors, and tumor dissemination to distant organs. It plays a significant role in the development of cancer.
Angiogenesis inhibitors are distinct from other cancer treatments in that they stop the development of blood vessels that promote tumor growth rather than the proliferation of tumor cells.
No, angiogenesis inhibitors are distinct from other cancer treatments in that they prevent the development of blood vessels that promote tumor growth rather than tumor cell growth.
Angiogenesis plays a crucial role in carcinogenesis. Solid tumors require a blood supply to grow larger than a few millimeters. Hence, angiogenesis is crucial to the development of cancer. Indeed, tumors can induce angiogenesis by emitting chemical signals that cause it to occur.
Angiogenesis inhibitors seem to work best in conjunction with other treatments. Anti-angiogenic drug use significantly increases overall survival for a number of malignancies.
The following are recognized angiogenesis inhibitors.
- Bevacizumab.
- Cabozantinib.
- Axitinib.
Last reviewed at:
19 Sep 2023 - 6 min read
RATING
Family Physician
Comprehensive Medical Second Opinion.Submit your Case
Advancements in Cancer Treatment
Article Overview: With advances in science, cancer treatment is not just the domain of surgery, but radiation therapy and chemotherapy equally contribute to its cure. Read Article
Introduction With advances in science, cancer treatment is not just the domain of surgery, but radiation therapy and chemotherapy equally contribute to its cure. The term cancer imbibes scare and imminent death in the minds of the patient and caregivers. Unfortunately, this reaction is justified bec... Read Article
Most Popular Articles
Do you have a question on Treatment Of Cancer or Angiogenesis Inhibitor?
Ask a Doctor Online